Having confirmed the efficacy of our synthetic peptide leptin mimetics in a number of mouse models of obesity and diabetes, we turned our attention to exploring the molecular basis of this activity. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.